[1]
J. Rogalski, O. Gawlik-Kotelnicka, and T. Tomczak, “Insights into risk factors of the Metabolic Dysfunction-Associated Steatotic Liver Disease development among patients with schizophrenia”, Curr Probl Psychiatry, vol. 25, pp. 226–238, Jan. 2025, doi: 10.12923/2353-8627/2024-0021.